Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Radiother. 2014 Mar;18(2):147-53; quiz 161, 163. doi: 10.1016/j.canrad.2013.11.009. Epub 2014 Jan 22.

[Radiation therapy of sinonasal natural killer/T-cell lymphoma].

[Article in French]

Author information

1
Service d'oncologie radiothéapie, groupe hospitalier Pitié-Salpêtrière (AP-HP), 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
2
Service d'hépatologie, groupe hospitalier Pitié-Salpêtrière (AP-HP), 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
3
Service d'oncologie radiothéapie, groupe hospitalier Pitié-Salpêtrière (AP-HP), 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: loic.feuvret@psl.aphp.fr.

Abstract

Natural killer (NK)/T-cell lymphoma are part of lymphoproliferative diseases, they are rare in Europe and the United States but relatively common in Asia and South America. Natural killer (NK)/T-cell lymphoma present clinically as destructive lesions of the upper aerodigestive tract with perforation of deep structures of the face, destruction of the palate or an invasion of orbits. Treatment modalities of these lymphomas are still discussed because of the lack of available studies and the rarity of this disease. Radiotherapy provides a rapid control of the disease and is positioned as a major treatment of localized stages of NK/T-cell lymphoma of the nasal cavity. We therefore studied the different forms of radiation therapy in the early stages of nasal NK/T-cell lymphoma.

KEYWORDS:

Association radiochimiothérapie; Chemotherapy; Chimiothérapie; Combined chemoradiation; Fosses nasales; Lymphome NK/T; Nasal cavity; Natural killer (NK)/T-cell lymphoma; Radiation therapy; Radiothérapie

PMID:
24462054
DOI:
10.1016/j.canrad.2013.11.009
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center